Company / Capital Returned to Shareholders per Share
Cytek Biosciences, Inc. Capital Returned to Shareholders per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.12
FY2025
5-year range
$0.00 / $0.34
FY2022-FY2025
Trend
-29.9%
vs FY2024
Sector context
#86 of 108
Health Care
What the data says
Cytek Biosciences, Inc.'s capital returned to shareholders per share of $0.12 is lower than 80% of companies in the Health Care sector (FY2025). Declined from $0.34 to $0.12 over the past 2 years.
Based on SEC 10-K filings.
0.12 in FY2025.
Declined from $0.34 to $0.12 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 108This company $0.12 Sector average $4.94
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 29.9% year-over-year.
- Ranks #86 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.12 | -29.9% |
| FY2024 | $0.17 | -50.5% |
| FY2023 | $0.34 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026